妇科肿瘤患者术后血栓预防药物依从性:一项子分析
本研究基于一项比较依诺肝素与阿哌沙班术后预防性抗凝安全性和有效性的随机对照试验,对400例妇科肿瘤患者数据行子分析,以术后28天内漏服≤2天药物定义依从性。非依从(64例)与较低生活质量评分、焦虑障碍史、药物满意度下降、基线用药更多、基线心率更高、术中操作更少、未行根治性子宫切除和/或淋巴结清扫、未达到术后2周里程碑及28天急诊就诊或再入院相关;多因素模型中非裔美国人种族、较低心理生活质量、忘记服药困难及28天急诊就诊或再入院可预测非依从。依诺肝素组较阿哌沙班组更常将非依从归因于疼痛或瘀斑(25.0% vs 3.1%,P=0.01)。
要点
- 术后28天漏服≤2天定义为依从,非依从64例。
- 非依从与较低生活质量评分、焦虑障碍史、药物满意度下降等相关。
- 多因素模型示非裔美国人种族、较低心理生活质量、忘记服药困难、28天急诊或再入院预测非依从。
核心结论
- 研究结果为了解妇科肿瘤患者术后药物依从性相关因素提供了新见解。
- 作者认为术前识别具有这些危险因素的患者并加强术后抗凝方案随访,可能有助于提高药物依从性。
研究设计与样本
- 对一项既往随机对照试验(N=400)行子分析,该试验比较妇科肿瘤患者术后预防性抗凝用依诺肝素与阿哌沙班的安全性和有效性。
- 依从性定义为术后28天内漏服≤2天药物(4片药或2次注射)。
- 与依从性相关的变量由研究作者预先选择。
- 单因素比较和多因素建模的统计学显著性阈值设为p<0.05。
主要发现
- 非依从(N=64)与较低生活质量评分、焦虑障碍史、药物满意度下降、基线用药更多、基线心率更高、术中操作总数更少、未行根治性子宫切除和/或淋巴结清扫、未达到术后2周里程碑及28天急诊就诊或再入院相关。
- 多因素模型中,非裔美国人种族、较低心理生活质量、忘记服药困难及28天急诊就诊或再入院可预测非依从。
- 依诺肝素组较阿哌沙班组更常将非依从归因于疼痛或瘀斑(25.0% vs 3.1%,P=0.01)。
临床怎么用
- 作者认为术前识别具有非依从危险因素的患者并加强术后抗凝方案随访,可能有助于提高药物依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Venous thromboembolism (VTE) is a major cause of morbidity and mortality among gynecologic cancer patients, especially in the immediate postoperative period. We sought to identify patterns related with patient non-adherence to postoperative prophylactic anticoagulation. METHODS: Participant data (N = 400) were reviewed from a previously conducted randomized controlled trial comparing the safety and efficacy of prophylactic postoperative anticoagulation with enoxaparin versus apixaban among gynecologic oncology patients. Variables hypothesized to be related to medication adherence were pre-selected by the study authors, and adherence was defined as missing ≤2 days of medication (4 pills or 2 injections) in 28 days postoperatively. For univariate comparisons and multivariate modeling, the threshold for statistical significance was set at p < .05. RESULTS: Non-adherence (N = 64) was associated with lower quality of life (QOL) score, history of anxiety disorder, decreased medication satisfaction, taking more medications at baseline, higher baseline heart rate, fewer total intraoperative procedures, not undergoing radical hysterectomy and/or lymph node dissection, not meeting 2-week postoperative milestones, and 28-day emergency department (ED) visit or readmission. African American race, lower mental QOL, difficulty remembering to take medication, and 28-day ED visit or readmission were predictive of non-adherence in a multivariate model. Patients taking enoxaparin versus apixaban more frequently attributed non-adherence to pain or bruising (25.0% vs. 3.1%, P = .01). CONCLUSION: Our findings provide new insights into factors associated with medication adherence that are particularly relevant to gynecologic oncology patients after surgery. Preoperative interventions to identify patients with these risk factors for more intensive followup of postoperative anticoagulation regimen may help increase medication adherence.
引用
- Ross ME, Glickman A, Brennecke A, et al. Adherence to postoperative thromboprophylactic medication among gynecologic oncology patients: A subanalysis. Gynecol Oncol. 2020. PMID: 32641236. doi:10.1016/j.ygyno.2020.06.505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。